Pharma Industry News

AZ to accelerate drug discovery with BenevolentAI partnership

The companies will create a team of two scientists that will work side-by-side to combine AstraZeneca’s genomics, chemistry and clinical data.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]